Comparison of pembrolizumab plus chemotherapy versus concurrent or sequential radiochemotherapy in patients with driver mutation-lacking lung adenocarcinoma presenting with recurrent laryngeal nerve invasion leading to hoarseness.

Zhuming Lu(Jiangmen Central Hospital), Zhihui Wang(Jiangmen Central Hospital), Tao Shen(Jiangmen Central Hospital), Shengshan Xu(Jiangmen Central Hospital), Ronggang Li(Fudan University), Zhichao Lin(Jiangmen Central Hospital), Jiarong Chen(Sun Yat-sen University), Min Ye(Jiangmen Central Hospital), Xin Zhang(Chinese National Human Genome Center), Mingzhang Chang(Jiangmen Central Hospital), Guoping Xiong(Jiangmen Central Hospital), Dongping Rao(Jiangmen Central Hospital)
Journal of Clinical Oncology
June 1, 2024
Cited by 10


Related Papers